ResearcherSeoul National UniversityActive in the last 2 years
Jong-chan Lee
Matched on OpenAlex author ID A5112327899. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 8
- Survival benefits of adjuvant chemotherapy after conversion surgery in patients with advanced pancreatic cancer. Co-author DOI 10.3389/fonc.2024.1510016↗
- Induction FOLFIRINOX followed by stereotactic body radiation therapy in locally advanced pancreatic cancer. Co-author DOI 10.3389/fonc.2022.1050070↗
- Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer. Co-author DOI 10.1371/journal.pone.0238649↗
- Involvement of the NF-κB signaling pathway in proliferation and invasion inhibited by Zwint-1 deficiency in Pancreatic Cancer Cells. Co-author DOI 10.7150/jca.46173↗
- Clinical outcomes of FOLFIRINOX in locally advanced pancreatic cancer: A single center experience. Co-author DOI 10.1097/md.0000000000013592↗
- Management of recurrent pancreatic cancer after surgical resection: a protocol for systematic review, evidence mapping and meta-analysis. Co-author DOI 10.1136/bmjopen-2017-017249↗
- Early versus delayed initiation of adjuvant treatment for pancreatic cancer. First author DOI 10.1371/journal.pone.0173960↗
- Clinical impact of neoadjuvant treatment in resectable pancreatic cancer: a systematic review and meta-analysis protocol. Co-author DOI 10.1136/bmjopen-2015-010491↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jin‐Hyeok Hwang · 8 shared papers, 2016–2024 · strength 1.04
- Paper Survival benefits of adjuvant chemotherapy after conversion surgery in patients with advanced pancreatic cancer. DOI 10.3389/fonc.2024.1510016↗
- Paper Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer. DOI 10.1371/journal.pone.0238649↗
- Paper Induction FOLFIRINOX followed by stereotactic body radiation therapy in locally advanced pancreatic cancer. DOI 10.3389/fonc.2022.1050070↗
- Jaihwan Kim · 7 shared papers, 2016–2022 · strength 0.82
- Paper Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer. DOI 10.1371/journal.pone.0238649↗
- Paper Induction FOLFIRINOX followed by stereotactic body radiation therapy in locally advanced pancreatic cancer. DOI 10.3389/fonc.2022.1050070↗
- Paper Involvement of the NF-κB signaling pathway in proliferation and invasion inhibited by Zwint-1 deficiency in Pancreatic … DOI 10.7150/jca.46173↗
- Hyoung Woo Kim · 3 shared papers, 2017–2020 · strength 0.35
- Paper Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer. DOI 10.1371/journal.pone.0238649↗
- Paper Clinical outcomes of FOLFIRINOX in locally advanced pancreatic cancer: A single center experience. DOI 10.1097/md.0000000000013592↗
- Paper Early versus delayed initiation of adjuvant treatment for pancreatic cancer. DOI 10.1371/journal.pone.0173960↗
- Dong Kee Jang · 1 shared paper, 2024 · strength 0.22
- Young Ae Kim · 1 shared paper, 2024 · strength 0.22
- Yoon Suk Lee · 1 shared paper, 2024 · strength 0.22
- Jung Won Chun · 1 shared paper, 2024 · strength 0.22
- Sang Myung Woo · 1 shared paper, 2024 · strength 0.22
- Jinwoo Ahn · 1 shared paper, 2022 · strength 0.16
- Kwangrok Jung · 1 shared paper, 2022 · strength 0.16
- Jae Hyup Jung · 1 shared paper, 2022 · strength 0.16
- Yuna Youn · 1 shared paper, 2020 · strength 0.15
- Jae Hyeong Kim · 1 shared paper, 2020 · strength 0.15
- In Kuk Cho · 1 shared paper, 2018 · strength 0.11
- Jin Won Kim · 1 shared paper, 2017 · strength 0.09
- Hyung Woo Kim · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.